Thyroid ultrasound for monitoring graves disease in children
Part of Eyes & vision, Hormones & metabolism, Immune system & allergy clinical trials.
This trial uses a special ultrasound to look at blood flow in the thyroid gland, which may help monitor how well treatment for Graves' disease is working in children. It is for children who are newly diagnosed with an overactive thyroid.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is newly diagnosed with hyperthyroidism (overactive thyroid), confirmed by blood tests showing high T4 and low TSH.
- Your child tested positive for TRAbs, which are antibodies that cause the thyroid to be overactive.
- Your child is not currently being treated with radioactive iodine.
- Your child has not had thyroid surgery.
- Your child has no history of neck radiation or neck surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding vitamin D therapy to the usual Graves' disease treatment (methimazole) can improve thyroid function and lower antibody levels in children. If your child is between 9 and 17 and recently diagnosed, they may be able to participate.
This trial tests an investigational drug called IMVT-1402 for people with Graves' disease whose thyroid is still overactive even while taking standard antithyroid medication. The goal is to see if the drug can better control thyroid hormone levels.
This trial tests a new drug called IMVT-1402 for adults with Graves' disease whose thyroid is still overactive despite taking antithyroid medication. The goal is to see if the drug can safely help control thyroid hormone levels.
This trial tests a new medicine called REGN24493 that may help control Graves' disease by blocking a specific receptor in the body. It is designed for adults who have been diagnosed with Graves' disease and are currently stable on their thyroid levels.
This study tests a new way to adjust thyroid medication doses for children with either congenital hypothyroidism or Graves' disease. It aims to help find the right dose more easily and improve treatment outcomes.
This study tests efgartigimod, a new medicine given by injection under the skin, to see if it can help control Graves' disease (an overactive thyroid condition). The goal is to reduce the need for other thyroid medications or help people stop taking them.
Hear when a new Graves Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.